PAGLIARO, Pasquale
 Distribuzione geografica
Continente #
NA - Nord America 17.800
EU - Europa 13.163
AS - Asia 7.166
SA - Sud America 258
AF - Africa 218
OC - Oceania 119
Continente sconosciuto - Info sul continente non disponibili 18
Totale 38.742
Nazione #
US - Stati Uniti d'America 17.452
IT - Italia 4.010
CN - Cina 3.634
IE - Irlanda 1.453
SE - Svezia 1.414
SG - Singapore 1.278
FR - Francia 1.152
DE - Germania 1.091
UA - Ucraina 991
FI - Finlandia 745
KR - Corea 725
GB - Regno Unito 697
PL - Polonia 474
JP - Giappone 346
VN - Vietnam 300
IN - India 233
CA - Canada 230
AT - Austria 193
ID - Indonesia 150
SN - Senegal 146
GR - Grecia 139
NL - Olanda 127
BR - Brasile 125
TR - Turchia 116
ES - Italia 106
MX - Messico 101
DK - Danimarca 94
AU - Australia 93
RU - Federazione Russa 89
HK - Hong Kong 88
BE - Belgio 86
TW - Taiwan 76
CH - Svizzera 56
AR - Argentina 46
IR - Iran 46
CL - Cile 43
CZ - Repubblica Ceca 43
HU - Ungheria 36
NO - Norvegia 35
RO - Romania 28
SA - Arabia Saudita 27
NZ - Nuova Zelanda 25
MU - Mauritius 23
PT - Portogallo 21
TH - Thailandia 21
KW - Kuwait 19
CO - Colombia 18
EU - Europa 17
IL - Israele 17
SK - Slovacchia (Repubblica Slovacca) 16
MY - Malesia 15
PK - Pakistan 15
EG - Egitto 14
PE - Perù 14
ZA - Sudafrica 14
UZ - Uzbekistan 11
EC - Ecuador 10
BA - Bosnia-Erzegovina 9
LT - Lituania 9
EE - Estonia 8
GE - Georgia 8
PH - Filippine 7
RS - Serbia 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
PA - Panama 6
HR - Croazia 5
IQ - Iraq 5
SI - Slovenia 5
AL - Albania 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
NP - Nepal 4
CI - Costa d'Avorio 3
KZ - Kazakistan 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
OM - Oman 3
QA - Qatar 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BT - Bhutan 2
CY - Cipro 2
HN - Honduras 2
IM - Isola di Man 2
LB - Libano 2
SM - San Marino 2
UG - Uganda 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BF - Burkina Faso 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
CV - Capo Verde 1
DZ - Algeria 1
KE - Kenya 1
Totale 38.733
Città #
Chandler 1.848
Beijing 1.700
Dublin 1.435
Santa Clara 1.155
Houston 1.069
Singapore 972
Ann Arbor 925
Fairfield 910
Ashburn 883
Jacksonville 755
Torino 673
Wilmington 524
Villeurbanne 503
Medford 480
Princeton 454
Woodbridge 434
Warsaw 411
Nyköping 384
Columbus 381
Seattle 378
Dearborn 359
Cambridge 333
Redwood City 312
Pisa 292
Turin 281
Dong Ket 218
Milan 214
Guangzhou 197
Boardman 196
Vienna 170
Nanjing 157
Shanghai 155
Boston 148
Fremont 139
Munich 136
Jakarta 131
Menlo Park 129
Rome 107
New York 87
Athens 85
Chengdu 77
Toronto 74
Falls Church 69
Helsinki 69
Xian 69
Wuhan 66
Hefei 65
San Diego 65
Hangzhou 63
Pune 60
Verona 59
Düsseldorf 58
Brussels 56
Norwalk 56
Shenyang 54
Washington 47
Florence 45
Phoenix 43
Chicago 40
Hebei 38
Tokyo 38
Changsha 37
Kunming 37
London 37
Nanchang 37
Zhengzhou 37
Hong Kong 36
Jinan 36
Ottawa 36
Taipei 35
Bologna 34
Fuzhou 32
Groningen 32
Rende 31
Santiago 30
Naples 29
Palermo 29
Silver Spring 29
Tianjin 28
Los Angeles 27
Piemonte 27
Bari 26
Frankfurt am Main 24
Lachine 24
Nuremberg 24
Seoul 24
Madrid 22
San Mateo 22
Chongqing 21
Guiyang 20
Mountain View 20
San Jose 18
Taichung 18
Budapest 17
Central District 17
Napoli 17
Oslo 17
Pescara 17
São Paulo 17
Barcelona 15
Totale 22.367
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.264
Ruolo della superossido dismutasi e della catalasi nella protezione ischemica indotta da buffer acido 576
Endogenous Cardioprotective Agents: Role in Pre and Postconditioning. 572
ADESIONE E VITALITÀ DELLE CELLULE STAMINALI MESENCHIMALI (MSC) MESSE IN COLTURA SU MICROSFERE POLIMERICHE 459
Mitochondrial Pathways, Permeability Transition Pore and Redox Signaling in Cardioprotection: Therapeutic Implications. 431
Redox balance and cardioprotection. 399
Physical activity/inactivity and COVID-19 382
COVID-19 associated cardiovascular morbidity in older adults. A position paper from the Italian Society of Cardiovascular Researches 381
Hypertension, hypertrophy, and reperfusion injury 372
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 363
Fisiologia cardiovascolare: un approccio integrato. 332
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 323
Cardiac Postconditioning. 315
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 313
A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion 309
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 308
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview 303
Catestatin Reduces Myocardial Ischaemia/Reperfusion Injury: Involvement of PI3K/Akt, PKCs, Mitochondrial KATP Channels and ROS Signalling. 298
The mechanical effects of Rhinoceros horned viper (Bitis nasicornis) venom on the isolated perfused guinea-pig heart 292
Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols 290
Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. 286
GH-Releasing Hormone Induces Cardioprotection in Isolated Male Rat Heart via Activation of RISK and SAFE Pathways 286
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 279
Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in Nandrolone treated rats 278
Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src 263
Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements:no role for SAFE 255
Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury. 254
Azione della proteina inibitrice IF1 sulla F0F1 ATPsintasi nell’iperemia reattiva coronarica prima e dopo il precondizionamento ischemico nella capra anestetizzata. 238
Fenotipizzazione di una linea cellulare mesenchimale continua ottenuta da polpa dentaria 237
Nanoprecipitated catestatin released from pharmacologically active microcarriers (PAMs) exerts pro-survival effects on MSC 235
Fisiologia renale. Con ebook 229
Cardioprotection against ischemia/reperfusion injury and chromogranin A derived peptides 225
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 223
Platelets, diabetes and myocardial ischemia/reperfusion injury 202
Protein S-nitrosylation in preconditioning and postconditioning 197
The effect of bioartificial constructs that mimic myocardial structure and biomechanical properties on stem cell commitment towards cardiac lineage. 195
Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial K(ATP) channels. 186
Postconditioning with diazoxide induces S-nytrosilation of mitochondrial proteins and cardioprotection against ischemia/reperfusion injury 186
Acidic infusion in early reperfusion affects the activity of antioxidant enzymes in postischemic isolated rat heart. 185
Human mesenchymal stem cells labelled with dye-loaded amorphous silica nanoparticles: Long-term biosafety, stemness preservation and traceability in the beating heart 182
Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α 180
Cardioprotective effects of calcitonin gene-related peptide in isolated rat heart and in H9c2 cells via redox signaling 179
Silica nanoparticles actively engage with mesenchymal stem cells in improving acute functional cardiac integration 177
Post-ischaemic activation of kinases in the preconditioning-like cardioprotective effect of the platelet activating factor. 176
Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway 174
Regulation of proteasome subunits activity by hydrogen sulfi de incultured cardiomyoblasts. 172
Role of temperature in myocardial ischemic injury and protection by conditioning 172
Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. 171
Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225 171
Sex and Gender Differences in Cardiovascular Diseases 171
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection 169
Muscle metaboreflex-induced increases in stroke volume. 160
Catestatin Improves Post-Ischemic Left Ventricular Function and Decreases Ischemia/Reperfusion Injury in Heart 159
Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. 159
Antineoplastic drug-induced cardiotoxicity: A redox perspective 159
A polymeric scaffold for cardiac regeneration and protection from reperfusion injury 158
null 154
Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species 153
Zoledronic Acid and Leuprorelin Acetate, Alone or in Combination, Similarly Reduce Proliferation and Migration of Prostate Cancer Cells In Vitro 151
Obestatin exerts post-conditioning-like cardioprotective effects via nitrosative/oxidative signaling 151
Post-Ischemic Early Acidosis in CardiacPostconditioning Modifies the Activity of AntioxidantEnzymes, Reduces Nitration and Favors ProteinS-Nitrosylation 150
POSCTCONTIONING CARDIOPROTECTION AFFECTS ANTIOXIDANT ENZYME ACTIVITY AND PROTEIN NITROSYLATION 145
Basic Cardiovascular Physiology From Molecules to Translational Medical Science 145
Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR. 144
Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts 144
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 141
A LIPOPHILIC NITRIC OXIDE-DONOR AND A LIPOPHILIC ANTIOXIDANT COMPOUND PROTECT RAT HEART AGAINST ISCHEMIA-REPERFUSION INJURY IF GIVEN AS HYBRID MOLECULE BUT NOT AS A MIXTURE. 139
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival 139
Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect. 139
Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: Role in oxidative stress 138
Nandrolone-pretreatment enhances cardiac beta(2)-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats 136
α-cyclodextrin and α-cyclodextrin polymers as oxygen nanocarriers to limit hypoxia/reoxygenation injury: Implications from an in vitro model 136
Spread bio oil diet and cardiac response to ischemia/reperfusion: A preliminary study in mice 134
Pre-conditioning cardioprotection mediated by the estrogen receptors in spontaneously hypertensive female rats 133
Role of catestatin as such or slowly released by fibronectin-coated pharmacologically-active-microcarriers (Fn-Pam) in limiting hypoxicinduced cell death 132
Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of b2-adrenoreceptors 129
Scaffold polimerico per la rigenerazione cardiaca e la protezione dai danni da riperfusione 128
Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: A feasibility study 127
Role of the fuel utilized by tissues on coronary vessel response to physical stimuli in isolated rat hearts 117
Role of perfusion mode on myocardial protection by pre- and post-conditioning 115
Biological and molecular effects of high doses of anabolic steroids 115
Playing with cardiac "redox switches": The "HNO way" to modulate cardiac function 114
Adult Stem Cells Meet Three-Dimensional Culture Environments: A Perspective in Myocardial Tissue Restoring 114
Intermittent bradykinin infusion in the early reperfusion phase mimics the cardioprotective effects of postconditioning 113
ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)? 113
Effects of bone marrow mesenchymal stem cells(BM-MSCs) on rat pial microvascular remodeling after transient middle cerebral artery occlusion 112
Modulation of cardiac contractility by muscle metaboreflex following efforts of different intensities in humans. 112
CARDIOPROTECTION BY POSTCONDITIONING (POSTC) IN NORMOTENSIVE AND HYPERTENSIVE RAT HEARTS: ROLE OF ANGIOTENSIN-CONVERTING ENZYME (ACE) 112
Nanosponge-cyclodextrins functionalized with oxygen protects H9C2 cells from hypoxia/reoxygenation injury: Implications from an in vitro model 112
Nandrolone enhances cardiac beta2-adrenoceptor expression and reverses contractile down-regulation in the post-stress period 109
A quantitative comparison between the two phases of the ventricular ejection. 108
Activity of apelin and APJ receptors on myocardial contractility and vasomotor tone 107
Dental pulp derived mesenchymal stem cells in myocardial infarction experimental models: preliminary results 106
'Resistance' to left ventricular outflow studied in anesthetized dogs. 105
Homing of bone marrow mesenchymal stem cell in infarcted myocardium immediately after ischemia 105
APELIN-INDUCED CARDIOPROTECTION INVOLVES PTEN INHIBITION BY SRC KINASE 105
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 105
The guidance of stem cell cardiomyogenic differentiation by PHBHV/gelatin bioartificial scaffolds mimicking myocardium structure. 104
Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury 103
Cardioprotective Effects of Angeli’s Salt Via Calcitonin Gene-Related Peptide (CGRP): Intracellular Signaling In Vitro 102
Totale 21.106
Categoria #
all - tutte 108.009
article - articoli 0
book - libri 0
conference - conferenze 38.597
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.620 0 0 0 0 0 950 569 361 446 456 543 295
2020/20215.342 519 280 417 382 568 383 529 259 634 413 330 628
2021/20224.749 211 232 273 412 314 215 336 306 210 453 811 976
2022/20236.429 700 361 185 556 637 1.631 507 451 707 212 298 184
2023/20243.426 359 517 177 193 293 521 161 208 29 179 261 528
2024/20254.048 121 590 337 750 1.789 461 0 0 0 0 0 0
Totale 40.066